Literature DB >> 15921898

Size and burden of social phobia in Europe.

Lydia Fehm1, Antoine Pelissolo, Tomas Furmark, Hans-Ulrich Wittchen.   

Abstract

This paper provides a critical review of the prevalence of social phobia in European countries, a description of associated disability and burden and of clinical correlates and risk factors associated with social phobia. On the basis of a comprehensive literature search we identified 21 community studies and two primary care studies. The median lifetime and 12-month prevalence rates of social phobia in community samples referring to DSM-III-R and DSM-IV criteria were 6.65% and 2.0%, respectively. Younger individuals showed the highest rates, and women were more frequently affected than men. Social phobia was shown to be a persistent condition with a remarkably high degree of comorbid conditions, associated impairment and disability. Research deficits lie in a lack of data for most EU countries and in a lack of studies in children and the elderly. No data are available addressing met and unmet needs for intervention and costs, and data for vulnerability and risk factors of malignant course are scarce.

Entities:  

Mesh:

Year:  2005        PMID: 15921898     DOI: 10.1016/j.euroneuro.2005.04.002

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  55 in total

1.  A 2010 evidence-based algorithm for the pharmacotherapy of social anxiety disorder.

Authors:  Dan J Stein; David S Baldwin; Borwin Bandelow; Carlos Blanco; Leonardo F Fontenelle; Sing Lee; Hisato Matsunaga; David Osser; Murray B Stein; Michael van Ameringen
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

Review 2.  Familial risk factors in social anxiety disorder: calling for a family-oriented approach for targeted prevention and early intervention.

Authors:  Susanne Knappe; Katja Beesdo-Baum; Hans-Ulrich Wittchen
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-10-06       Impact factor: 4.785

3.  Shyness versus social phobia in US youth.

Authors:  Marcy Burstein; Leila Ameli-Grillon; Kathleen R Merikangas
Journal:  Pediatrics       Date:  2011-10-17       Impact factor: 7.124

Review 4.  Efficacy and tolerability of second-generation antidepressants in social anxiety disorder.

Authors:  Richard A Hansen; Bradley N Gaynes; Gerald Gartlehner; Charity G Moore; Ruchi Tiwari; Kathleen N Lohr
Journal:  Int Clin Psychopharmacol       Date:  2008-05       Impact factor: 1.659

5.  The Role of Traumatic Experiences and Posttraumatic Stress on Social Anxiety in a Youth Sample in Lithuania.

Authors:  Monika Kvedaraite; Paulina Zelviene; Ask Elklit; Evaldas Kazlauskas
Journal:  Psychiatr Q       Date:  2020-03

6.  Social phobia in Swedish adolescents : prevalence and gender differences.

Authors:  Malin Gren-Landell; Maria Tillfors; Tomas Furmark; Gunilla Bohlin; Gerhard Andersson; Carl Göran Svedin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-29       Impact factor: 4.328

7.  Recognizing and managing anxiety disorders in primary health care in Turkey.

Authors:  Mehtap Kartal; Ozlem Coskun; Nesrin Dilbaz
Journal:  BMC Fam Pract       Date:  2010-04-28       Impact factor: 2.497

Review 8.  The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.

Authors:  Baptiste Pignon; Chloé Tezenas du Montcel; Louise Carton; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2017-11-07       Impact factor: 5.285

9.  Evaluation of the psychometric properties of a modified version of the Social Phobia Screening Questionnaire for use in adolescents.

Authors:  Malin Gren-Landell; Andreas Björklind; Maria Tillfors; Tomas Furmark; Carl Göran Svedin; Gerhard Andersson
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-11-11       Impact factor: 3.033

10.  Associations of familial risk factors with social fears and social phobia: evidence for the continuum hypothesis in social anxiety disorder?

Authors:  Susanne Knappe; Katja Beesdo; Lydia Fehm; Roselind Lieb; Hans-Ulrich Wittchen
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.